“ Recombinant Factor VIIa Is Associated With an Improved 24-Hour Survival Without an Improvement in Inpatient Survival in Massively Transfused Civilian Trauma Patients ”. 2011. Clinics 66 (1): 101-6. https://doi.org/10.1590/S1807-59322011000100018.